我国皮肤科医生的特应性皮炎用药选择情况分析  

Analysis on Medications Prescribed by Chinese Dermatologists for the Treatment of Atopic Dermatitis

作　　者：胡宇晴 刘萍[1] 王雨馨[1] 胡坚[1] 于聪[1] 李厚敏[1] 张建中[1] HU Yuqing;LIU Ping;WANG Yuxin;HU Jian;YU Cong;LI Houmin;ZHANG Jianzhong(Department of Dermatology,Peking University People′s Hospital,Beijing 100044,China)

机构地区：[1]北京大学人民医院皮肤科,北京100044

出　　处：《中国皮肤性病学杂志》2024年第7期748-754,共7页The Chinese Journal of Dermatovenereology

摘　　要：目的通过问卷调查分析我国皮肤科医生治疗特应性皮炎(atopic dermatitis,AD)的用药选择倾向。方法线上向国内皮肤科医生发放调查问卷,调查我国皮肤科医生对AD的诊疗观念和治疗选择,采用SPSS23.0对数据进行统计分析。结果共2258名皮肤科医生参与调查,轻中度AD最常用的药物为外用钙调磷酸酶抑制剂(66.96%)和口服抗组胺药物(74.49%);中重度AD最常用的治疗为系统使用复方甘草酸苷(66.78%)、系统使用糖皮质激素(48.85%)和生物制剂(47.79%)。结论我国皮肤科医生对于AD治疗的选择各不相同,其治疗规范性有待提高。Objective To analyze the choices of medication used by Chinese dermatologists for treating atopic dermatitis(AD)through a questionnaire survey.Methods The survey was conducted through an online platform that asked Chinese dermatologists about the therapeutic approaches and treatment behaviors for AD patients.The results were statistically analyzed using SPSS23.0.Results A total of 2258 Chinese dermatologists participated in the survey.The results showed that for mild and moderate AD,the most frequently used medications were topical calcineurin inhibitors(66.96%)and oral antihistamine agents(74.49%).On the other hand,for moderate to severe AD,the most frequently used medications were systemic compound glycyrrhizin(66.78%),systemic glucocorticoids(48.85%)and biologic agents(47.79%).Conclusion The study concluded that the therapeutic options for AD used by Chinese dermatologists varied greatly.This highlights the need to improve the standard treatment available for AD.

关 键 词：特应性皮炎 治疗 皮肤科医生 用药选择 

分 类 号：R758.2[医药卫生—皮肤病学与性病学]